Monoclonal antibodies provide protection against a wide range of infectious microbes, and now, in a series of elegant ...

In February 2025 Harbour BioMed announced that the IND application for HBM9378 (SKB378), a TSLP-targeting monoclonal antibody ...

The eight new ACIP members met for the first time June 25 after Kennedy fired all 17 original members of the committee June 9 ...

Unlike rabies, which causes roughly 59,000 human deaths annually, predominantly in Africa and Asia, human infection with bat ...

A newly configured federal vaccine panel's June 25 action is expected to improve options to protect infants from potentially ...

In a bold move that could reshape the future of biomedical research, Boster Bio is launching a Free Antibody Validation ...

Nipocalimab's FDA approval revolutionizes generalized myasthenia gravis treatment, offering rapid symptom relief and improved ...

At a recent Senate hearing, Health and Human Services Secretary Robert F. Kennedy Jr. said something I never thought I’d hear ...

There is no specific medicine for dengue yet. If ongoing Phase III trials yield positive results, an effective, affordable & specific antiviral would be available, 'ultimately saving more lives'.

During early drug development and preclinical development, researchers use in vitro cultured lymphocytes to induce cytokine ...